Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nina Reschke"'
Autor:
Yvonne Grübler, Mirela Matzner, Carsten Riether, Matteo Bianchi, Aline Eggenschwiler, Vladimir Kirkin, Kyriaki Ioannou, Waleed Ali, Simone Ragusa, Stefanie Fischer, Bernd Schlereth, Alienor Auge, Christian Reichen, Denis Villemagne, Adrian F. Ochsenbein, Jennifer Krieg, Anne Goubier, Martin Hänggi, Daniel Steiner, Patricia Spitzli, Thamar Looser, Ursina Luethi, Marco Franchini, Christel Herzog, Nina Reschke, Yvonne Kaufmann
Publikováno v:
Blood. 138:1164-1164
AML is driven by leukemic stem cells (LSC) that resist conventional chemotherapies and remain unaffected in their niche, continually replenishing circulating blast cells. We postulated that an avidity-engineered CD3 engaging DARPin ® (Designed Ankyr
Autor:
Bernd Schlereth, Alexandra Neculcea, Nicole Bassler, Daniel Steiner, Sebastian Grimm, Nina Reschke, Yvonne Gruebler, Thamar Looser, Laura Jeanbart, Jennifer Krieg, Matteo Bianchi, Patricia Schildknecht, Tanja Hospodarsch, Christian Reichen
Publikováno v:
Cancer Research. 81:525-525
Purpose: The medical need due to high mortality in acute myeloid leukemia (AML) remains high, and the treatment of relapsed or refractory AML continues to be therapeutically challenging. MYLOTARG, the only approved anti-CD33 antibody drug conjugate (